Improving Access to Care for Veterans With Memory Loss
Recruiting · NCT07117162 · Interventional (participants receive a specific treatment) · Lead sponsor: VA Pittsburgh Healthcare System
View the official record on ClinicalTrials.gov →Interventions studied
ADRD Care Delivery Protocol
What this trial is about
This study evaluates a care delivery protocol to improve access to care for Veterans with Alzheimer's Disease and Related Disorders (ADRD). A randomized controlled trial will enroll Veterans with mild cognitive impairment or early dementia at VA Pittsburgh. The ADRD care delivery protocol integrates telehealth, advanced diagnostics, and streamlined workflows to expedite screening for eligibility for amyloid targeting therapies.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosis of mild cognitive impairment or mild dementia due to suspected or confirmed AD with a 5 minute telephone MoCA score \>7
- Meets VA MUE inclusion/
Exclusion criteria
- for mAb therapy for AD
- Enrolled in VA care
- Lives in a home setting (i.e., not in an institutional setting such as a nursing home, Community Living Center, or hospital)
- Has a working telephone
- 18 years and older
- Able to communicate in English
- Willing to give informed consent.
- Exclusion Criteria:
- None
Where it is running
1 location listed across 1 US state.
- VA Pittsburgh Healthcare System - Pittsburgh, Pennsylvania, United States